4//SEC Filing
Duey Marc 4
Accession 0001104659-24-111548
CIK 0001781983other
Filed
Oct 24, 8:00 PM ET
Accepted
Oct 25, 5:42 PM ET
Size
6.7 KB
Accession
0001104659-24-111548
Insider Transaction Report
Form 4
Duey Marc
Director
Transactions
- Sale
Common Stock
2024-10-18$4.58/sh−6,462$29,583→ 233,651 total
Holdings
- 602(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]The Reporting Person's sale of Issuer's common stock reported herein was automatically transacted by the Reporting Person's broker as a result of an insufficient cash position in the Reporting Person's brokerage account. Further, the Reporting Person's sale of Issuer's common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 (i) to the extent of 190 shares, with the Reporting Person's purchase of 190 shares of the Issuer's common stock at a price of $2.5837 on October 14, 2024, and (ii) to the extent of 6,272 shares, with the Reporting Person's purchase of 30,000 shares of the Issuer's common stock at a price of $4.39 per share on October 16, 2024. The Reporting Person has agreed to pay to Issuer $1,558.05 which represents the full amount of the profit realized in connection with the short-swing transaction.
- [F2]These shares were sold in multiple transactions on October 18, 2024, each at $4.578 per share.
- [F3]The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, or for any other purpose.
Documents
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
Related Parties
1- filerCIK 0001925150
Filing Metadata
- Form type
- 4
- Filed
- Oct 24, 8:00 PM ET
- Accepted
- Oct 25, 5:42 PM ET
- Size
- 6.7 KB